Gregory A Jicha Selected Research

Cholinesterase Inhibitors (Anticholinesterases)

11/2011	Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.
1/2009	Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory A Jicha Research Topics

Disease

51	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 10/2008
24	Dementia (Dementias) 11/2023 - 05/2006
16	Cognitive Dysfunction 01/2023 - 03/2006
6	Amyloid Plaque 01/2022 - 07/2009
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023 - 10/2008
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 03/2010
5	Hippocampal Sclerosis 01/2018 - 05/2011
4	limbic-predominant age-related TDP-43 encephalopathy 08/2023 - 01/2019
4	Brain Diseases (Brain Disorder) 01/2022 - 08/2006
4	Proteostasis Deficiencies 01/2022 - 01/2020
4	Tauopathies 01/2019 - 12/2014
3	TDP-43 Proteinopathies 01/2022 - 01/2019
2	Disease Progression 12/2023 - 01/2009
2	Hypoxia (Hypoxemia) 01/2023 - 11/2015
2	Inflammation (Inflammations) 01/2023 - 01/2021
2	Arteriolosclerosis 01/2023 - 08/2017
2	Hyperhomocysteinemia 01/2022 - 01/2021
2	Chronic Traumatic Encephalopathy 01/2021 - 01/2018
2	Hypertension (High Blood Pressure) 01/2021 - 01/2019
2	Atrophy 01/2018 - 12/2014
2	Lewy Body Disease (Lewy Body Dementia) 01/2018 - 10/2008
2	Atherosclerosis 01/2017 - 10/2008
2	Synucleinopathies 01/2017 - 02/2013
2	Frontotemporal Dementia (Semantic Dementia) 12/2016 - 04/2011
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 07/2015 - 05/2011
1	Pathologic Processes 12/2023
1	Neuroinflammatory Diseases 11/2023
1	Infections 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Chronic Brain Injury 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	COVID-19 01/2020
1	Postoperative Cognitive Complications 04/2019
1	Overweight 01/2019
1	Craniocerebral Trauma (Head Injury) 01/2019

Drug/Important Bio-Agent (IBA)

28	Biomarkers (Surrogate Marker)IBA 11/2023 - 06/2012
16	Amyloid (Amyloid Fibrils)IBA 12/2023 - 07/2009
13	Apolipoproteins E (ApoE)IBA 01/2023 - 10/2008
12	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2011
11	ApolipoproteinsIBA 01/2022 - 03/2006
5	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 07/2009
4	SynucleinsIBA 08/2023 - 01/2017
3	Peptides (Polypeptides)IBA 08/2023 - 01/2016
3	Islet Amyloid PolypeptideIBA 01/2023 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 11/2023 - 01/2023
2	ProteomeIBA 08/2023 - 01/2022
2	tau Proteins (tau Protein)IBA 08/2023 - 01/2021
2	Amyloid beta-PeptidesIBA 01/2023 - 01/2021
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 04/2010
2	Cholinergic Antagonists (Anticholinergics)IBA 04/2020 - 05/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2011
2	Thyroid HormonesIBA 01/2019 - 12/2016
2	MicroRNAs (MicroRNA)IBA 12/2017 - 06/2012
2	Indicators and Reagents (Reagents)IBA 01/2017 - 01/2013
2	Eosine Yellowish-(YS) (Eosin)IBA 07/2015 - 05/2011
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2011 - 01/2009
1	Interleukin-10 (Interleukin 10)IBA 11/2023
1	Interleukin-8 (Interleukin 8)IBA 11/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	CytokinesIBA 01/2023
1	VaccinesIBA 01/2023
1	HomocysteineIBA 01/2022
1	Detergents (Detergent)IBA 01/2022
1	Vitamin B Complex (B Vitamins)IBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2021
1	tetramethylthiuram monosulfide FDA Link 04/2020
1	Adaptor Protein Complex 2IBA 01/2020
1	Mucin-6IBA 01/2020
1	alpha 2 subunit adaptor protein complex 2IBA 01/2020
1	Anesthetics (Anesthetic Agents)IBA 04/2019
1	Inhalation AnestheticsIBA 04/2019
1	Hypnotics and Sedatives (Sedatives)IBA 04/2019
1	Complement System Proteins (Complement)IBA 01/2018
1	Pemetrexed (MTA)FDA Link 01/2018
1	platelet membrane glycoprotein VIIBA 01/2017
1	Becaplermin (PDGF-BB)FDA Link 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	diethylstilbestrol monophosphate (PDES)IBA 01/2017
1	Angiopoietin-1IBA 01/2017
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2017
1	Large Neutral Amino Acid-Transporter 1IBA 01/2017
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2017
1	Muscarinic AntagonistsIBA 01/2017
1	Platelet-Derived Growth FactorIBA 01/2017
1	von Willebrand FactorIBA 01/2017
1	Vitamin E FDA LinkGeneric 12/2016
1	SynaptophysinIBA 12/2016
1	Synaptotagmins (Synaptotagmin)IBA 12/2016

Therapy/Procedure

7	Therapeutics 12/2023 - 04/2009
1	Polypharmacy 10/2023
1	Occupational Therapy (Therapy, Occupational) 07/2023
1	Psychosurgery (Lobotomy) 01/2021
1	Hand Hygiene 01/2020
1	Deprescriptions 12/2019
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019
1	Secondary Prevention 04/2017